These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17361230)

  • 41. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.
    Vidovic K; Ullmark T; Rosberg B; Lennartsson A; Olofsson T; Nilsson B; Gullberg U
    Leuk Res; 2013 Oct; 37(10):1341-9. PubMed ID: 23871158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia.
    Barragán E; Cervera J; Bolufer P; Ballester S; Martín G; Fernández P; Collado R; Sayas MJ; Sanz MA
    Haematologica; 2004 Aug; 89(8):926-33. PubMed ID: 15339675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis.
    Baird PN; Simmons PJ
    Exp Hematol; 1997 Apr; 25(4):312-20. PubMed ID: 9131006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of the Wilms' tumor gene (WT1) in human leukemias.
    Miwa H; Beran M; Saunders GF
    Leukemia; 1992 May; 6(5):405-9. PubMed ID: 1317488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of p21 by the Wilms' tumor suppressor gene WT1.
    Englert C; Maheswaran S; Garvin AJ; Kreidberg J; Haber DA
    Cancer Res; 1997 Apr; 57(8):1429-34. PubMed ID: 9108440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of the Wilms' tumor 1 gene (WT1) and its role in hematopoiesis and leukemia.
    Algar E
    J Hematother Stem Cell Res; 2002 Aug; 11(4):589-99. PubMed ID: 12201948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. WT1 vaccination in acute myeloid leukemia: new methods of implementing adoptive immunotherapy.
    Rein LA; Chao NJ
    Expert Opin Investig Drugs; 2014 Mar; 23(3):417-26. PubMed ID: 24521058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in the Wilms' tumor gene WT1 in leukemias.
    King-Underwood L; Renshaw J; Pritchard-Jones K
    Blood; 1996 Mar; 87(6):2171-9. PubMed ID: 8630376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells.
    Ellisen LW; Carlesso N; Cheng T; Scadden DT; Haber DA
    EMBO J; 2001 Apr; 20(8):1897-909. PubMed ID: 11296223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [WT1-targeting cancer vaccine].
    Sugiyama H
    Nihon Rinsho; 2012 Dec; 70(12):2105-13. PubMed ID: 23259381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The CUG-translated WT1, not AUG-WT1, is an oncogene.
    Lee KY; Jeon YJ; Kim HG; Ryu J; Lim DY; Jung SK; Yu DH; Chen H; Bode AM; Dong Z
    Carcinogenesis; 2017 Dec; 38(12):1228-1240. PubMed ID: 29040381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The many facets of the Wilms' tumour gene, WT1.
    Hohenstein P; Hastie ND
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R196-201. PubMed ID: 16987884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wilms' tumour gene 1 (WT1) in human neoplasia.
    Keilholz U; Menssen HD; Gaiger A; Menke A; Oji Y; Oka Y; Scheibenbogen C; Stauss H; Thiel E; Sugiyama H
    Leukemia; 2005 Aug; 19(8):1318-23. PubMed ID: 15920488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).
    Toska E; Roberts SG
    Biochem J; 2014 Jul; 461(1):15-32. PubMed ID: 24927120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The modulation of WTI transcription function by cofactors.
    Roberts SG
    Biochem Soc Symp; 2006; (73):191-201. PubMed ID: 16626299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia.
    Hossain A; Nixon M; Kuo MT; Saunders GF
    J Biol Chem; 2006 Sep; 281(38):28122-30. PubMed ID: 16698800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.